Cisco IOS XE & Cisco IOS XE SDWAN Ethernet Frame DoS (cisco-sa-le-drTOB625)

Medium Nessus Plugin ID 141437

New! Vulnerability Priority Rating (VPR)

Tenable calculates a dynamic VPR for every vulnerability. VPR combines vulnerability information with threat intelligence and machine learning algorithms to predict which vulnerabilities are most likely to be exploited in attacks. Read more about what VPR is and how it's different from CVSS.

VPR Score: 3.6


The remote device is missing a vendor-supplied security patch


According to its self-reported version, Cisco IOS XE or Cisco IOS XE SDWAN is affected by a denial of service (DoS) vulnerability in its networking component due to a failure to handle malformed ethernet frames. An unauthenticated, adjacent attacker can exploit this issue, by sending specially crafted ethernet frames to an affected device, to force a reload of the device.

Please see the included Cisco BIDs and Cisco Security Advisory for more information.

Note that Nessus has not tested for these issues but has instead relied only on the application's self-reported version


Upgrade to the relevant fixed version referenced in Cisco bug ID CSCvu30597

See Also

Plugin Details

Severity: Medium

ID: 141437

File Name: cisco-sa-le-drTOB625-iosxe.nasl

Version: 1.4

Type: local

Family: CISCO

Published: 2020/10/14

Updated: 2020/10/15

Dependencies: 67217

Risk Information

Risk Factor: Medium

VPR Score: 3.6

CVSS Score Source: CVE-2020-3465

CVSS v2.0

Base Score: 6.1

Temporal Score: 4.5

Vector: CVSS2#AV:A/AC:L/Au:N/C:N/I:N/A:C

Temporal Vector: CVSS2#E:U/RL:OF/RC:C

CVSS v3.0

Base Score: 6.5

Temporal Score: 5.7

Vector: CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Temporal Vector: CVSS:3.0/E:U/RL:O/RC:C

Vulnerability Information

CPE: cpe:/o:cisco:ios_xe

Required KB Items: Host/Cisco/IOS-XE/Version

Exploit Ease: No known exploits are available

Patch Publication Date: 2020/09/24

Vulnerability Publication Date: 2020/09/24

Reference Information

CVE: CVE-2020-3465


CISCO-SA: cisco-sa-le-drTOB625

IAVA: 2020-A-0439

CWE: 20